P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis ; volume:2 ; number:3 ; day:15 ; month:9 ; year:2008 ; pages:114 ; date:8.2008
Artery research ; 2, Heft 3 (15.9.2008), 114, 8.2008
- Urheber
-
Baou, K.
Vlachopoulos, C.
Manesis, E.
Dima, I.
Pietri, P.
Terentes-Printzios, D.
Ioakeimidis, N.
Archimandritis, A.
Stefanadis, C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1016/j.artres.2008.08.398
- URN
-
urn:nbn:de:101:1-2405021258472.653456911832
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baou, K.
- Vlachopoulos, C.
- Manesis, E.
- Dima, I.
- Pietri, P.
- Terentes-Printzios, D.
- Ioakeimidis, N.
- Archimandritis, A.
- Stefanadis, C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
P1.06 Is Impaired Fasting Glucose Associated with Subclinical Arterial Disease? the Strong Heart Study
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
Subclinical heart failure in juvenile idiopathic arthritis: a consequence of chronic inflammation and subclinical atherosclerosis
Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive
Value of the arterial stiffness index and ankle brachial index in subclinical atherosclerosis screening in healthy community-dwelling individuals
Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
P1.06 Is Impaired Fasting Glucose Associated with Subclinical Arterial Disease? the Strong Heart Study
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
Subclinical heart failure in juvenile idiopathic arthritis: a consequence of chronic inflammation and subclinical atherosclerosis
Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive
Value of the arterial stiffness index and ankle brachial index in subclinical atherosclerosis screening in healthy community-dwelling individuals
Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
P1.06 Is Impaired Fasting Glucose Associated with Subclinical Arterial Disease? the Strong Heart Study
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
Subclinical heart failure in juvenile idiopathic arthritis: a consequence of chronic inflammation and subclinical atherosclerosis
Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive
Value of the arterial stiffness index and ankle brachial index in subclinical atherosclerosis screening in healthy community-dwelling individuals